Multimodal analysis enables the simultaneous measurement of multiple modalities or the integration of data from multiple experiments. For a long time now, the advantages of sequencing mRNA (scRNA – Seq) in individual cells, to understand...
Read More »BD launches simultaneous RNA and protein expression analysis assay
Becton Dickinson today announced the commercial release of the BD® AbSeq assay to analyze protein expression at the single-cell level using high-throughput sequencing. The assay brings together high-quality antibodies from the BD Pharmingen™ portfolio with oligonucleotides, allowing researchers to perform ...
Read More »BD Expands Genomics Portfolio with New Single Cell Platform for RNA Expression Analysis
BD (Becton, Dickinson and Company) , a leading global medical technology company, today announced the launch of BD Rhapsody, a platform for single cell analysis with the ability to detect rare molecules responsible for biological diversity that are often missed with ...
Read More »Early Access Program for New Single-Cell Gene Expression Platform Announced
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced an early access program for the BD Resolve™ Single-Cell Gene Expression platform that has the flexibility to capture and analyze hundreds to tens of thousands ...
Read More »